Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers-Reference-Cited by-同舟云学术

Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers

Published:2022-11-05 Issue:3 Volume:30 Page:1312-1326
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Clark Nina M.,Roberts Emma A.,Fedorenko Catherine,Sun Qin,Dubard-Gault Marianne,Handford Cynthia,Yung Rachel,Cheng Heather H.,Sham Jonathan G.,Norquist Barbara M.,Flanagan Meghan R.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-022-12755-y.pdf

Reference65 articles.

1. Alsop K, Fereday S, Meldrum C, et al. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol. 2012;30:2654–63. https://doi.org/10.1200/JCO.2011.39.8545.

2. Economopoulou P, Dimitriadis G, Psyrri A. Beyond BRCA: new hereditary breast cancer susceptibility genes. Cancer Treat Rev. 2015;41(1):1–8. https://doi.org/10.1016/j.ctrv.2014.10.008.

3. Kurian AW, Ward KC, Howlader N, Deapen D, Hamilton AS, Mariotto A, Katz SJ. Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol. 2019;37(15):1305.

4. Leongamornlert D, Saunders E, Dadaev T, Tymrakiewicz M, Goh C, Jugurnauth-Little S, Kote-Jarai Z. Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease. Br J Cancer. 2014;110(6):1663–72. https://doi.org/10.1038/bjc.2014.30.

5. Norquist BM, Harrell MI, Brady MF, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2(4):482–90. https://doi.org/10.1001/jamaoncol.2015.5495.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumors, Treatments, and Trust: Cancer Characteristics, Outcomes, and Screening Uptake in Transgender and Gender-Diverse Patients;Annals of Surgical Oncology;2024-06-11

2. Impact of barriers and motivators on intention and confidence to undergo hereditary cancer genetic testing;Journal of Genetic Counseling;2024-05-27

3. Evaluation of the Influence of Geodimensional and Histological Parameters on the Need for Margin Widening in Breast Lesions Marked With Magnetic Seeds;European Journal of Breast Health;2024-01-01

4. Pancreatic Cancer Health Disparity: Pharmacologic Anthropology;Cancers;2023-10-20

5. The Role of the Surgeon in the Germline Testing of the Newly Diagnosed Breast Cancer Patient;Current Oncology;2023-05-01